OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic modifications of histones in cancer
Zibo Zhao, Ali Shilatifard
Genome biology (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 447

Showing 1-25 of 447 citing articles:

Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski, Mateusz Kciuk, Renata Kontek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3233-3233
Open Access | Times Cited: 1270

Epigenetics in hepatocellular carcinoma
Ganji Purnachandra Nagaraju, Begum Dariya, Prameswari Kasa, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 622-632
Closed Access | Times Cited: 191

The Contribution of Epigenetics to Cancer Immunotherapy
Lorea Villanueva, Damiana Álvarez‐Errico, Manel Esteller
Trends in Immunology (2020) Vol. 41, Iss. 8, pp. 676-691
Open Access | Times Cited: 188

Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai, Zhi Zhu, Shudipto Wahed, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 187

Targeted protein degradation: A promise for undruggable proteins
Kusal T. G. Samarasinghe, Craig M. Crews
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 934-951
Open Access | Times Cited: 186

Protein arginine methyltransferases: promising targets for cancer therapy
Jee Won Hwang, Yena Cho, Gyu‐Un Bae, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 5, pp. 788-808
Open Access | Times Cited: 182

Single-cell proteomics enabled by next-generation sequencing or mass spectrometry
Hayley M. Bennett, William Stephenson, Christopher M. Rose, et al.
Nature Methods (2023) Vol. 20, Iss. 3, pp. 363-374
Closed Access | Times Cited: 178

Methods for ChIP-seq analysis: A practical workflow and advanced applications
Ryuichiro Nakato, Toyonori Sakata
Methods (2020) Vol. 187, pp. 44-53
Open Access | Times Cited: 176

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Jianwei Qu, Haimeng Yan, Yifan Hou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 141

Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Robert Jenke, Nina Reßing, Finn K. Hansen, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 634-634
Open Access | Times Cited: 137

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 86

Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 54

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 42

Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 29

Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 2

Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance
Homa Fatma, S. Maurya, Hifzur R. Siddique
Seminars in Cancer Biology (2020) Vol. 83, pp. 166-176
Closed Access | Times Cited: 98

Polyphenols as Caloric-Restriction Mimetics and Autophagy Inducers in Aging Research
Assylzhan Yessenkyzy, Timur Saliev, Marina Zhanaliyeva, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1344-1344
Open Access | Times Cited: 96

Ionizing Radiation-Induced Epigenetic Modifications and Their Relevance to Radiation Protection
M. Belli, Maria Antonella Tabocchini
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5993-5993
Open Access | Times Cited: 96

PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
Bing Yao, Tao Gui, Xiangwei Zeng, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 96

Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
Maite G. Fernández‐Barrena, María Arechederra, Leticia Colyn, et al.
JHEP Reports (2020) Vol. 2, Iss. 6, pp. 100167-100167
Open Access | Times Cited: 94

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
Reem Saleh, Salman M. Toor, Varun Sasidharan Nair, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 80

Transcription and Translation Inhibitors in Cancer Treatment
Nihay Laham-Karam, Gaspar Pinto, Antti Poso, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 76

The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling
Yanchun Zhao, Yunhao Chen, Mei Ling Jin, et al.
Theranostics (2021) Vol. 11, Iss. 9, pp. 4549-4566
Open Access | Times Cited: 73

Contributions of Histone Variants in Nucleosome Structure and Function
Hitoshi Kurumizaka, Tomoya Kujirai, Yoshimasa Takizawa
Journal of Molecular Biology (2020) Vol. 433, Iss. 6, pp. 166678-166678
Open Access | Times Cited: 71

Page 1 - Next Page

Scroll to top